- 微生物專用設備
- 細胞專用設備
- 基礎理化設備
- 溶液處理移液設備
- 蛋白質專用設備
- Cellpro
- 試劑類
- 培養基類
- 實驗室耗材類
- 儀器維修&校正服務
- 防疫專區
- infitek系列
- pakgent系列
- 塑膠耗材類別
- 冷藏冰箱
-
商品資訊
Description
Application
The POCT Immunofluorescence Quantitative Analyzer is used cooperatively with special fluoroimmunoassay reagent strips and applicable to fluoroimmunoassay of human body samples. The product can be used for semiquantitative and quantitative immunoassay of medical, antiepidemic and scientific research institutions.
Features
- Ultra-high Sensitivity and excellent precision.
- Fast and Flexible, result in short time.
- Intelligent QR code management.
- Real-time data transmission, compatible with LIS/HIS.
- Store 10,000 results.
- Largetouch screen LCD display.
Specifications
Model IFA-S1000 Test Item The product is used cooperatively with immunofluorescence assay kit produced by our company. Excitation Light Source LED Wavelength Range 740nm Test Item Parameter Thecan read configuration parameters of the instrument from information card. Sample Type Whole blood, serum, plasma, urine and faeces (subject to specification of immunofluorescence assay kit) Delay Test Delay test time can be set. Place test card in the instrument and test at fixed time after completion of reaction Test Speed 240 times/hour Background Number Fluorescence value should be ≤5 Repeatability The variable coefficient of fluorescence value of fluorescence test cards of different intensities repeatedly measured by the instrument CV≤2.0% Stability The relative deviation between the test result at 4th hour and the 8th hour after the instrument is working stably and the test result when the instrument just works stably is limited to ±3.0%.
Accuracy When the instrument tests the calibrated fluorescence test card, the deviation between the measured fluorescence value and the calibration value of the fluorescence test card is ±3.0%. Measuring Time The time from inserting the fluorescence test card to displaying the test result should not exceed 15s. Linearity Range Within the concentration range of standards no less than two orders of magnitudes, the linearly dependent coefficient of the fluorescence value and concentration read by the instrument r≥0.990 Electricity AC 100V-240V 50Hz/60Hz; Host: DC12V 5A Input Power 60 VA Dimension 200*300*140mm Net Weight 2.0kg Menu of assays
Biomarkers Product Item Specimen Reaction Time Measuring Range Clinical Range Intended Use Cardiac cTnl WB/Serum/Plasma 12min. 0.1-40ng/mL <0.3ng/mL Several heart diseases including myocardial infarction and heart failure. Myo WB/Serum/Plasma 12min. 5-400ng/mL <58ng/mL Acute myocardial infarction (AMI) in early stage. CK-MB WB/Serum/Plasma 12min. 1-200ng/mL <5ng/mL Acute myocardial infarction (AMI) in early stage. NT-proBNP WB/Serum/Plasma 10min. 20-35000pg/mL Under75:0~347pg/mL
Over75:0~449pg/mLHeart failure. D-Dimer WB/Plasma 10min. 40-10000ng/mL <500ng/mL Disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction,etc. cTnl+Myo+ CKMB
WB/Serum/Plasma 12min. Same with single item Same with single item Triple marker of myocardial infarction. ST2 WB/Serum/Plasma 10min. 10-400ng/mL <35ng/mL Heart failure. Lp-PLA2 WB/Serum/Plasma 10min. 10-900ng/mL <175ng/mL Risk evaluation of ACS and atherosclerotic ischemic stroke patients. H-FABP WB/Serum/Plasma 10min. 2.5-160ng/mL <5ng/mL Acute myocardial infarction (AMl) in early stage. HCY WB/Serum/Plasma 15min. 1-50μmol/L 5-15μmol/L Atherosclerosis, venous embolism, coronary heart disease. Inflammation CRP/hs-CRP WB/Serum/Plasma 3min. 0.5-200mg/L CRP<10mg/L
hs-CRP<1mg/LNonspecficity inflammatory marker. SAA WB/Serum 5min. 1-200mg/L <10mg/L Inflammation &infection. PCT WB/Serum/Plasma 10min. 0.2-100ng/mL <0.5ng/mL Sepsis. CRP+SAA WB/Serum/Plasma 5min. Same with single item Same with single item Inflammation &infection. IL-6 WB/Serum/Plasma 10min. 5-4000pg/mL 10pg/mL Diabetes, rheumatoid arthritis,etc. Calprotectin Fecal specimens 10min. 5-1000mg/g <50mg/g Enteritis. Thyroid Hormone
TSH WB/Serum/Plasma 15min. 0.3-100mU/L 0.3-4.2mU/L Hyperthyroidism and hypothyroidism. T3 WB/Serum/Plasma 15min. 0.5-10nmol/L 1.23-3.07nmol/L Thyroid dysfunction. Tπ4 WB/Serum/Plasma 15min. 5-300nmol/L 66-181nmol/L Thyroid dysfunction. FT3 WB/Serum/Plasma 15min. 1-50pmol/L 3.1-6.8pmol/L Thyroid dysfunction. FT4 WB/Serum/Plasma 15min. 5-100pmol/L 12-22pmol/L Thyroid dysfunction. Tumor Maker
AFP WB/Serum/Plasma 10min. 2.5-200ng/mL <20ng/mL Pregnancy cancer. CEA WB/Serum/Plasma 10min. 1-200ng/mL <5ng/mL Colon cancer, colorectal cancer,etc. NSE WB/Serum/Plasma 10min. 1-400ng/mL <16ng/mL Non-small cell lung cancer. FOB Fecal specimens 10min. 50-1000ng/mL <100ng/mL Abnormal recessive gastrointestinal bleeding. PGIⅡI WB/Serum/Plasma 10min. 1-100ug/L PGI/PGII>3.0 Gastric abnormalities. PGI WB/Serum/Plasma 10min. 2.5-200ug/L >70ng/mL Gastric abnormalities. TPSA WB/Serum/Plasma 10min. 0.5-40ng/mL <4ng/mL Prostate cancer. FPSA WB/Serum/Plasma 10min. 0.1-10ng/mL <1ng/mL Prostate cancer. CA12-5 WB/Serum/Plasma 10min. 20-500U/mL <35U/mL Ovarian cancer. CA15-3 WB/Serum/Plasma 10min. 10-400U/mL <25U/mL Breast cancer. HE4 WB/Serum/Plasma 10min. 50-2000pmol/L <140pmol/L Ovarian cancer. CA19-9 WB/Serum/Plasma 10min. 10-400U/mL <27U/mL Pancreatic cancer. HCG WB/Serum/Plasma 10min. 5-400mIU/mL <10mIU/mL Early pregnancy, ectopic HCG cancer, incomplete abortion. CK19 (Cyfra21-1)
WB/Serum/Plasma 10min. 1-100ng/mL <3.3ng/mL Non-small cell lung cancer. -
商品Q&A